Skip to main content

A Chemokin Driven Regenerative Pharmacologic Approach to Urinary Incontinence

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 3, 2014
Award amount: 
$88,231
Organization name: 
Wake Forest University Health Sciences
Principal Investigator: 
Williams, James Koudy
Grant program category: 
Research and Equipment Support
Grant program name: 
Biotechnology Research Grant
Region: 
Piedmont

The goal of this study is to test the effectiveness and safety of using a chemokine (CXCL12) to treat urinary incontinence in a rat model. These studies will be done under GLP-compliant conditions with a focus on submission to the FDA for IND approval and commercialization of this technology.

Fiscal year: 
2014